A Comprehensive Single Institutional Review of 2 Years in a Designated Fast-Track Sarcoma Diagnostic Clinic Linked with a Sarcoma Specialist Advisory Group: Meeting the Target but Failing the Task?

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left"><i>Metastatic cancer</i></td><td class="align_center"> </td></tr><tr><td class="align_left">Breast cancer</td><td class="align_center">2</td></tr><tr><td class="align_left">Colorectal cancer</td><td class="align_center">1</td></tr><tr><td class="align_left">Lung cancer</td><td class="align_center">3</td></tr><tr><td class="align_left">Renal cell carcinoma </td><td class="align_center">2</td></tr><tr><td class="align_left">Transitional cell carcinoma </td><td class="align_center">1</td></tr><tr><td class="align_left">Paraganglioma</td><td class="align_center">1</td></tr><tr><td class="align_left">Squamous cell carcinoma (skin)</td><td class="align_center">1</td></tr><tr><td class="align_left">Nonseminomatous germ cell tumour</td><td class="align_center">1</td></tr><tr><td class="align_left"><i>Primary cancer</i></td><td class="align_center"> </td></tr><tr><td class="align_left">Classical Hodgkin’s lymphoma</td><td class="align_center">1</td></tr><tr><td class="align_left">Cutaneous marginal zone lymphoma </td><td class="align_center">1</td></tr><tr><td class="align_left">Follicular lymphoma</td><td class="align_center">3</td></tr><tr><td class="align_left">High grade B-cell lymphoma</td><td class="align_center">1</td></tr><tr><td class="align_left">Anaplastic large cell lymphoma</td><td class="align_center">1</td></tr><tr><td class="align_left">Mantle cell lymphoma </td><td class="align_center">1</td></tr><tr><td class="align_left">Plasmacytoma</td><td class="align_center">5</td></tr><tr><td class="align_left">Myeloma</td><td class="align_center">1</td></tr><tr><td class="align_left">Merkel cell carcinoma </td><td class="align_center">1</td></tr><tr><td class="align_left">Urachal adenocarcinoma</td><td class="align_center">1</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Sarcoma

tab6

Table 6

Table 6: A Comprehensive Single Institutional Review of 2 Years in a Designated Fast-Track Sarcoma Diagnostic Clinic Linked with a Sarcoma Specialist Advisory Group: Meeting the Target but Failing the Task? 

Table 6 | A Comprehensive Single Institutional Review of 2 Years in a Designated Fast-Track Sarcoma Diagnostic Clinic Linked with a Sarcoma Specialist Advisory Group: Meeting the Target but Failing the Task? 